Karl Dietmann

This inventor holds 19 USPTO granted patents, primarily in Cardiac Therapeutics. Top assignees: Boehringer Mannheim Gmbh, C.f. Boehringer & Soehne Gmbh. Active years: 1976-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl Dietmann. Retrieved from https://idiyas.com/inventor/karl-dietmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19

% Patents Active = 100.0

Average Co-Inventor Count = 5.4

ph-index = 8

Forward Citations = 217(Granted Patents)

Location History:

Mannheim, DE (1978 - 1984)
Mannheim-Vogelstang, DE (1976 - 1985)

Company Filing History:

18 out of 1,164

Boehringer Mannheim Gmbh

patents

1 out of 1

C.f. Boehringer & Soehne Gmbh

patent

Years Active: 1976-1985

Loading Chart...

Areas of Expertise:

Carbazolyl Compounds

Aminopropanol

Cardioactive Agents

Adrenergic Inhibitors

Heterocyclic Compounds

Indole Derivatives

Therapeutic Compositions

Blood Pressure Lowering

Pharmaceutical Compositions

Adenosine Derivatives

Piperazine Compounds

Tricyclic Derivatives

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4503067 - Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compositions (1985-03-05),

2. 4468520 - 3-Cyano-indoles as cardioselective agents (1984-08-28),

3. 4438128 - Cardioactive aryloxypropanolamines (1984-03-20),

4. 4378363 - Certain heterocyclic-carboxamido-phenoxy-aminopropanols, compositions (1983-03-29),

5. 4346093 - Heterocyclic oxypropanolamine compounds and pharmaceutical compositions (1982-08-24),

6. 4229464 - Aminopropanol substituted indole compounds and compositions for the (1980-10-21),

7. 4224438 - Adenosine-5'-carboxylic acid amides (1980-09-23),

8. 4152446 - Aminopropanol compounds and compositions for the treatment of cardiac (1979-05-01),

9. 4146630 - Blood pressure lowering and adrenergic .beta.-receptor inhibiting (1979-03-27),

10. 4120963 - Certain pyrido[3,4-b]indole-1-ones (1978-10-17),

11. 4087520 - Lowering blood pressure with new (1978-05-02),

12. 4076829 - Aminopropanol compounds and compositions for the treatment of cardiac (1978-02-28),

13. 4070373 - Tricyclic aminoalkyl derivatives (1978-01-24),

14. 4029783 - N-substituted 1-amino-3-phenoxy-propan-2-ol compounds and therapeutic (1977-06-14),

15. 4016262 - Therapeutic compositions and methods employing N(6)-disubstituted (1977-04-05),

Title: Karl Dietmann: A Pioneer in Therapeutic Innovations

Introduction

Karl Dietmann, based in Mannheim-Vogelstang, Germany, is an esteemed inventor recognized for his significant contributions in the field of biochemistry and pharmacology. With a total of 19 patents to his name, Dietmann's work has greatly influenced therapeutic compositions aimed at treating heart and circulatory diseases.

Latest Patents

Among his latest innovative patents are the Carbazolyl-(4)-oxypropanolamine compounds and 3-Cyano-indoles as cardioselective agents. The first patent involves a new class of compounds crucial for various therapeutic applications, involving specific structural formulas which cater to unique chemical properties. The second patent describes aminopropanol derivatives, emphasizing the importance of pharmacological salts and their processes in preparation, which further enhance their utility in medical science.

Career Highlights

Karl Dietmann has built his illustrious career working with renowned companies such as Boehringer Mannheim GmbH and C. F. Boehringer & Soehne GmbH. His tenure at these firms allowed him to focus on creating innovative solutions and advancements in pharmaceutical chemistry, significantly contributing to the field of therapeutics.

Collaborations

Throughout his career, Dietmann collaborated with notable coworkers, including Wolfgang Kampe and Max Thiel. Their collective expertise and innovative spirit fueled the development of groundbreaking inventions that have reshaped therapeutic approaches within the pharmaceutical industry.

Conclusion

In conclusion, Karl Dietmann stands out as a significant figure in the realm of innovations and inventions related to therapeutic compounds. His prolific output of patents showcases his dedication to improving healthcare solutions, particularly in treating heart and circulatory diseases. With a strong foundation in research and collaboration, Dietmann continues to inspire future generations of inventors and innovators in the pharmaceutical field.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]